載入中
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
前收盤價
US$5.845
+US$0.305 · +5.51%
盤前
US$5.80
−US$0.045 · -0.77%
10月9日 上午7:00 ET
盤中時間採用ET。市場資料可能有所延遲。
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
日內區間
目前US$5.845
52週區間
目前US$5.845
盤中時間採用ET。市場資料可能有所延遲。
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
日內區間
目前US$5.845
52週區間
目前US$5.845
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 4405.1萬 USD | 3263.4萬 USD | 2039.8萬 USD | 1674.2萬 USD | 1301萬 USD |
| 銷貨成本 | 1008.2萬 USD | 808.4萬 USD | 603.5萬 USD | 433.1萬 USD | 498.6萬 USD |
| 毛利 | 3396.9萬 USD | 2455萬 USD | 1436.3萬 USD | 1241.1萬 USD | 802.4萬 USD |
| 研究與開發 | 135.3萬 USD | 67.3萬 USD | 57.9萬 USD | 56.7萬 USD | 110.1萬 USD |
| 銷售、一般及管理費用 | 2679.1萬 USD | 1767.1萬 USD | 1357.2萬 USD | 2003萬 USD | 2028.1萬 USD |
| 營業費用 | 2902.4萬 USD | 1913.3萬 USD | 1490.3萬 USD | 2136.3萬 USD | 2216.6萬 USD |
| 利息支出 | 624.6萬 USD | 1363.7萬 USD | 1562.3萬 USD | 1413.2萬 USD | 709.5萬 USD |
| 折舊和攤銷 | 128.3萬 USD | 114.5萬 USD | 102.8萬 USD | 95.2萬 USD | 123.6萬 USD |
| 營業利益 | 494.5萬 USD | 541.7萬 USD | −54萬 USD | −895.2萬 USD | −1414.2萬 USD |
| 淨利 | 1181.3萬 USD | −3137.2萬 USD | −2580.7萬 USD | −1029.3萬 USD | −2725.9萬 USD |
公司資料更新於 2026年10月9日。
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
Invesco NASDAQ Future Gen 200 ETFQQQS
iShares Micro-Cap ETFIWCAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
